Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale CSO, Head Res.&Non-Clin. Dev. sold 48,368 shares at $24.34 ($1,177,277)
  2. 4 Open-market sale Director sold 10,000 shares at $24.27 ($242,680)
  3. 4 Open-market sale President and CEO sold 9,562 shares at $18.57 ($177,566)
  4. 4 Open-market sale 10% owner sold 24,777 shares at $24.34 ($603,072)
  5. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $18.10 ($45,250)
  6. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  7. 4 Open-market sale Director sold 5,000 shares at $17.30 ($86,476)
  8. 4/A Open-market sale President and CEO sold 9,930 shares at an average $17.33 ($172,054)
  9. 4/A Open-market sale President and CEO sold 18,756 shares at an average $17.50 ($328,260)
  10. 4 Open-market sale 10% owner sold 20,000 shares at $18.00 ($360,000)
  11. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $17.17 ($42,925)
  12. 4 Open-market sale President and CEO sold 9,930 shares at $17.32 ($171,988)
  13. 4 Open-market sale President and CEO sold 18,756 shares at an average $17.50 ($328,260)
  14. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $15.00 ($37,500)
  15. 4 Open-market sale President and CEO sold 4,781 shares at $15.00 ($71,715)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Auditor change
  19. 4 Other disposition 10% owner disposed of 850,000 shares (other)
  20. SC 13G/A Stake Amended Statement of Ownership

Page 30 of 41 · 801 filings